Prosecution Insights
Last updated: October 04, 2026

H.U. Group Research Institute G.K.

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials

3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready

Analysis

H.U. Group Research Institute G.K. currently manages 3 pending office actions within the Biotechnology & Pharmaceuticals technology area. This portfolio is distributed across 3 distinct examiners and 3 distinct art units. The distribution suggests that the company is navigating different specialized silos within the patent office rather than concentrating its efforts under a single supervisory authority.

The busiest examiner for this portfolio is SCHLOOP, ALLISON ELIZABETH, who is responsible for 1 of the pending office actions. Because there are 3 distinct examiners in total, the workload is not concentrated under one person. This dispersion can lead to varied prosecution outcomes as each of the 3 distinct art units may apply different internal guidelines or examination standards.

With 1 busiest examiner pending action assigned to SCHLOOP, ALLISON ELIZABETH, the immediate administrative burden per examiner is limited. The presence of the Biotechnology & Pharmaceuticals technology area confirms that the subject matter is being evaluated from different technical perspectives. This variety requires a flexible strategy to address the specific requirements of each examiner involved. Practitioners should monitor these 3 pending office actions for unique examiner behaviors.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

3
Total Pending OAs
1
Non-Final OAs
1
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

3
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (33%)
Multi-statute (no §101)2 (67%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

3
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

30 h
Manual time on pending OAs
6 h
Time saved (low, 20%)
10 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SCHLOOP, ALLISON ELIZABETH 1 63.0% +56.5%
GERIDO, DWAN A 1 58.0% +30.4%
CORDAS, EMILY ANN 1 50.8% +57.3%

Hard Cases (3)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18165574 METHOD FOR RECOVERING EXTRACELLULAR VESICLES GERIDO, DWAN A 8d
18247806 ONE OR MORE KINDS OF HLA GENE PRIMERS SCHLOOP, ALLISON ELIZABETH —
17787720 METHOD FOR RECOVERING EXTRACELLULAR VESICLE AND BLOOD COLLECTION VESSEL CORDAS, EMILY ANN —

Interview Candidates (3)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18165574 METHOD FOR RECOVERING EXTRACELLULAR VESICLES GERIDO, DWAN A 8d
18247806 ONE OR MORE KINDS OF HLA GENE PRIMERS SCHLOOP, ALLISON ELIZABETH —
17787720 METHOD FOR RECOVERING EXTRACELLULAR VESICLE AND BLOOD COLLECTION VESSEL CORDAS, EMILY ANN —

Top Art Units

Art UnitApps
1683 1
1797 1
1600 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18247806 ONE OR MORE KINDS OF HLA GENE PRIMERS SCHLOOP, ALLISON ELIZABETH 1683 §101§103§112 Non-Final OA — Pending Apr 04, 2023
18165574 METHOD FOR RECOVERING EXTRACELLULAR VESICLES GERIDO, DWAN A 1797 §102§103 Final Rejection 8d Pending Feb 07, 2023
17787720 METHOD FOR RECOVERING EXTRACELLULAR VESICLE AND BLOOD COLLECTION VESSEL CORDAS, EMILY ANN 1600 §103§112Other Non-Final OA — Pending Jun 21, 2022

Managing H.U. Group Research Institute G.K.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month